U.N. COVID-19 Therapy Trial Pauses Hydroxychloroquine Testing Due to Report of Higher Death Risk
U.N. COVID-19 Therapy Trial Pauses Hydroxychloroquine Testing Due to Report of Higher Death Risk
TIME
0 shares
1 views
You might like
Related news coverage
UN virus therapy trial pauses hydroxychloroquine testing
SeattlePI.com
GENEVA (AP) — The World Health Organization said Monday that it will temporarily drop hydroxychloroquine — the anti-malarial..
-
UN virus therapy trial pauses hydroxychloroquine testing
Seattle Times
-
An Aspirin A Day Does Not Keep Dementia At Bay
Eurasia Review